Global Gynecology Partnering Report 2010-2017: Deal Trends, Players and Financials

DUBLIN, September 8, 2017 /PRNewswire/ --

The "Global Gynecology Partnering 2010-2017: Deal trends, players and financials" report has been added to Research and Markets' offering.

Global Gynecology Partnering 2010-2017: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals.

The report presents financial deal terms values for Gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Gynecology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Gynecology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Gynecology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Gynecology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Gynecology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities.

Chapter 6 provides a comprehensive directory of all Gynecology partnering deals by specific Gynecology target announced since 2010. The chapter is organized by specific Gynecology therapeutic target.

Report scope:

• Trends in Gynecology dealmaking in the biopharma industry since 2010
• Analysis of Gynecology deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Gynecology deal contract documents
• Comprehensive access to over 3500 Gynecology deal records
• The leading Gynecology deals by value since 2010
• Most active Gynecology dealmakers since 2010
  

In Global Gynecology Partnering 2010 to 2017, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Gynecology dealmaking

Chapter 3 -Financial deal terms for Gynecology partnering

Chapter 4 - Leading Gynecology deals and dealmakers

Chapter 5 - Gynecology contract document directory

Chapter 6 - Gynecology dealmaking by therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/6bx58r/global_gynecology

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets